Stay updated on Dolatav Clinical Trial: Nucleoside Sparing in HIV-1

Sign up to get notified when there's something new on the Dolatav Clinical Trial: Nucleoside Sparing in HIV-1 page.
Latest website image capture
Clouds background image

Latest updates to the Dolatav Clinical Trial: Nucleoside Sparing in HIV-1 page

  1. Check
    3 days ago
    Change Detected
    Summary
    A site-wide notice about government funding lapse and NIH operating status was added, and the revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T03:26:29.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option and new metadata fields including 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and the revision label 'v3.4.0'. Removed the older entries 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and the previous revision label 'v3.3.4'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T00:39:02.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision: v3.3.4 is now displayed and Revision: v3.3.3 has been removed. This appears to be a minor version label update rather than substantive content.
    Difference
    0.1%
    Check dated 2026-01-14T01:57:01.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Footer now displays 'Revision: v3.3.3'. The HHS Vulnerability Disclosure link and the previous 'Revision: v3.3.2' entry were removed.
    Difference
    0.1%
    Check dated 2025-12-23T22:29:25.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    The Publications section now includes a note stating that publications are provided voluntarily by the person entering information and pertain to the study results. The revision tag was updated to v3.3.2, replacing v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-25T10:35:09.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    The page no longer displays the government funding status notice related to NIH operations; the core study details and sections remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T06:52:27.000Z thumbnail image

Stay in the know with updates to Dolatav Clinical Trial: Nucleoside Sparing in HIV-1

Enter your email address, and we'll notify you when there's something new on the Dolatav Clinical Trial: Nucleoside Sparing in HIV-1 page.